Cubist Systematic Strategies buys $7,773,987 stake in Align Technology (ALGN)

Align Technology (ALGN) : Cubist Systematic Strategies scooped up 72,587 additional shares in Align Technology during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 86,167 shares of Align Technology which is valued at $7,773,987.Align Technology makes up approximately 0.50% of Cubist Systematic Strategies’s portfolio.

Other Hedge Funds, Including , Healthcor Management sold out all of its stake in ALGN during the most recent quarter. The investment firm sold 41,730 shares of ALGN which is valued $3,764,881.Teacher Retirement System Of Texas reduced its stake in ALGN by selling 2,434 shares or 23.99% in the most recent quarter. The Hedge Fund company now holds 7,712 shares of ALGN which is valued at $661,150. Cibc World Markets added ALGN to its portfolio by purchasing 39,806 company shares during the most recent quarter which is valued at $3,426,500. Align Technology makes up approx 0.01% of Cibc World Markets’s portfolio. Biondo Investment Advisors added ALGN to its portfolio by purchasing 3,400 company shares during the most recent quarter which is valued at $292,672. Align Technology makes up approx 0.10% of Biondo Investment Advisors’s portfolio.Advisors Asset Management boosted its stake in ALGN in the latest quarter, The investment management firm added 6,354 additional shares and now holds a total of 31,515 shares of Align Technology which is valued at $2,664,908. Align Technology makes up approx 0.05% of Advisors Asset Management’s portfolio.

Align Technology closed down -2.4 points or -2.47% at $94.84 with 9,51,448 shares getting traded on Monday. Post opening the session at $97.73, the shares hit an intraday low of $94.8 and an intraday high of $98.62 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Align Technology reported $0.63 EPS for the quarter, beating the analyst consensus estimate by $ 0.12 according to the earnings call on Nov 7, 2016. Analyst had a consensus of $0.51. The company had revenue of $278.58 million for the quarter, compared to analysts expectations of $270.64 million. The company’s revenue was up 34.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.

Many Wall Street Analysts have commented on Align Technology. Robert W. Baird Downgraded Align Technology on Oct 3, 2016 to ” Neutral”, Price Target of the shares are set at $96.

Align Technology Inc. (Align) is a medical device company. The Company designs manufactures and markets a system of clear aligner therapy intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services for dentistry orthodontics and dental records storage. The Company operates through two segments: Clear Aligner known as the Invisalign system and Scanners and Services known as the iTero intraoral scanner and OrthoCAD services. The Company’s Clear Aligner segment provides malocclusion and orthodontic treatment. The Company’s Scanners and Services Segment offers iTero intraoral scanner which utilizes laser and optical scanning to capture the contours of the patient’s dentition gingival structures and the bite. It distributes products directly to customers including orthodontists and general practitioner dentists (GPs) as well as to restorative dentists including prosthodontists periodontists and oral surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Align Technology - Is it time to Sell?

Top Brokerage Firms are advising their investors on Align Technology. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.